Paydirt
HC
Insider

Helen Louise Collins

CHIEF MEDICAL OFFICER

Helen Louise Collins (CHIEF MEDICAL OFFICER) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $1.4M of ELVN (40,000 sh × $35.10, as filed), executed Mar 25.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
Sep 17
Filed yesterday

Median ADV $83.7M across their filed names

Open performance
Volume by month
$2.7M$1.4M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2026 · sells $1.2MMar 2026 · sells $2.7MApr 2026 · sells $232KMay 2026 · sells $137KJun 2026 · sells $114KJul 2026 · sells $225KAug 2026 · sells $228KSep 2026 · sells $146K
Buys $0 Sells $5.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names
ELVN Enliven Therapeutics, Inc. ELVN · 0 buys · 10 sells 10 filings
Recent filings
ELVNSALE Enliven Therapeutics, Inc. View filing → $1.2M
40,000 sh across 2 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET
ELVNSALE Enliven Therapeutics, Inc. View filing → $1.2M
45,000 sh × $26.17
Exec Feb 17
Filed Feb 19 · 5:30 PM ET